West Michigan Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.15M Hold
29,796
0.91% 24
2026
Q1
$4.15M Buy
29,796
+3,091
+12% +$433K 0.91% 24
2025
Q4
$3.28M Buy
26,705
+4,173
+19% +$507K 0.75% 32
2025
Q3
$2.5M Buy
22,532
+18,264
+428% +$2.08M 0.6% 47
2025
Q2
$473K Sell
4,268
-1,439
-25% -$153K 0.13% 117
2025
Q1
$639K Buy
+5,707
New +$589K 0.21% 80
2022
Q1
Sell
-5,352
Closed -$389K 135
2021
Q4
$389K Buy
+5,352
New +$369K 0.29% 67

Other funds holding GILD

West Michigan Advisors's GILD Position: Q2 2026 in Review

West Michigan Advisors held its Gilead Sciences (GILD) position steady in Q2 2026 at 29,796 shares worth $4.15M. The position accounts for 0.91% of the portfolio, ranked #24.

West Michigan Advisors first reported a position in GILD in Q4 2021 and has held it in 7 quarters since. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • West Michigan Advisors held 29,796 shares of Gilead Sciences worth $4.15M as of Q2 2026.
  • West Michigan Advisors left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.91% of West Michigan Advisors's portfolio in Q2 2026, its #24 holding.
  • West Michigan Advisors first reported a position in Gilead Sciences in Q4 2021 and has held it in 7 quarters since.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on West Michigan Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.